Complexin-2 Inhibitors

Complexin-2 inhibitors encompass a class of chemicals that indirectly affect the function of Complexin-2, a protein implicated in the regulation of neurotransmitter release at synapses. Complexin-2 is known to bind to SNARE complexes, which are critical for the fusion of synaptic vesicles with the presynaptic membrane to release neurotransmitters. Therefore, chemicals that disrupt SNARE complex formation or function can indirectly inhibit Complexin-2. Such chemicals include those that target the individual SNARE proteins, such as tetanus toxin and botulinum toxin, which cleave synaptobrevin and other SNARE proteins, thereby preventing the assembly of functional SNARE complexes. Similarly, clostridial toxins and compounds like N-Ethylmaleimide (NEM) that modify SNARE proteins interfere with their normal function and, by extension, the role of Complexin-2.

The class also includes chemicals that affect the cellular processes associated with neurotransmitter release. For instance, calcium channel blockers like ω-conotoxin GVIA and ω-agatoxin IVA reduce calcium influx, which is essential for triggering the fusion of vesicles mediated by SNARE complexes and Complexin-2. On the other hand, compounds like Dynasore and Clathrin inhibitors that impair vesicle trafficking indirectly affect the availability of synaptic vesicles for release, thereby influencing Complexin-2 function. Actin dynamics are also crucial for vesicle movement and synaptic function; thus, agents like Latrunculin A and Jasplakinolide, which disrupt or stabilize actin filaments, respectively, can also alter Complexin-2 activity at the synapse.